Sameh Abdelmalak: Dr. Giuseppe Curigliano discussing ASCO24 DESTINY-Breast06

Sameh Abdelmalak, Director, Oncology, Educational Partnerships at VuMedi, made the following post on X:

“Check out Check out Dr. Giuseppe Curigliano, discussing ASCO24 ‘DESTINY-Breast06 – T-DXd vs. Physician’s Choice of Chemotherapy in HR+/HER2-Low/Ultralow mBC After Endocrine Therapy’.

Full video on VuMedi.”

Video attached to the post.
Source: Sameh Abdelmalak/X